Literature DB >> 29125414

Resection of gliomas deemed inoperable by neurosurgeons based on preoperative imaging studies.

Derek G Southwell1, Harjus S Birk2, Seunggu J Han1, Jing Li1, Jeffrey W Sall3, Mitchel S Berger1.   

Abstract

OBJECTIVE Maximal safe resection is a primary objective in the management of gliomas. Despite this objective, surgeons and referring physicians may, on the basis of radiological studies alone, assume a glioma to be unresectable. Because imaging studies, including functional MRI, may not localize brain functions (such as language) with high fidelity, this simplistic approach may exclude some patients from what could be a safe resection. Intraoperative direct electrical stimulation (DES) allows for the accurate localization of functional areas, thereby enabling maximal resection of tumors, including those that may appear inoperable based solely on radiological studies. In this paper the authors describe the extent of resection (EOR) and functional outcomes following resections of tumors deemed inoperable by referring physicians and neurosurgeons. METHODS The authors retrospectively examined the cases of 58 adult patients who underwent glioma resection within 6 months of undergoing a brain biopsy of the same lesion at an outside hospital. All patients exhibited unifocal supratentorial disease and preoperative Karnofsky Performance Scale scores ≥ 70. The EOR and 6-month functional outcomes for this population were characterized. RESULTS Intraoperative DES mapping was performed on 96.6% (56 of 58) of patients. Nearly half of the patients (46.6%, 27 of 58) underwent an awake surgical procedure with DES. Overall, the mean EOR was 87.6% ± 13.6% (range 39.0%-100%). Gross-total resection (resection of more than 99% of the preoperative tumor volume) was achieved in 29.3% (17 of 58) of patients. Subtotal resection (95%-99% resection) and partial resection (PR; < 95% resection) were achieved in 12.1% (7 of 58) and 58.6% (34 of 58) of patients, respectively. Of the cases that involved PR, the mean EOR was 79.4% ± 12.2%. Six months after surgery, no patient was found to have a new postoperative neurological deficit. The majority of patients (89.7%, 52 of 58) were free of neurological deficits both pre- and postoperatively. The remainder of patients exhibited either residual but stable deficits (5.2%, 3 of 58) or complete correction of preoperative deficits (5.2%, 3 of 58). CONCLUSIONS The use of DES enabled maximal safe resections of gliomas deemed inoperable by referring neurosurgeons. With rare exceptions, tumor resectability cannot be determined solely by radiological studies.

Entities:  

Keywords:  ADP = afterdischarge potential; DES = direct electrical stimulation; DTI = diffusion tensor imaging; EOR = extent of resection; GTR = gross-total resection; KPS = Karnofsky Performance Scale; MAC = minimum alveolar concentration; MSI = magnetic source imaging; PR = partial resection; STR = subtotal resection; TMS = transcranial magnetic stimulation; direct electrical stimulation; eloquent tumor; glioma; oncology; resection

Mesh:

Year:  2017        PMID: 29125414     DOI: 10.3171/2017.5.JNS17166

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  13 in total

Review 1.  Brain connectomics applied to oncological neuroscience: from a traditional surgical strategy focusing on glioma topography to a meta-network approach.

Authors:  Hugues Duffau
Journal:  Acta Neurochir (Wien)       Date:  2021-02-09       Impact factor: 2.216

Review 2.  Quantitative mapping of the brain's structural connectivity using diffusion MRI tractography: A review.

Authors:  Fan Zhang; Alessandro Daducci; Yong He; Simona Schiavi; Caio Seguin; Robert E Smith; Chun-Hung Yeh; Tengda Zhao; Lauren J O'Donnell
Journal:  Neuroimage       Date:  2022-01-01       Impact factor: 7.400

3.  CyberKnife for Recurrent Malignant Gliomas: A Systematic Review and Meta-Analysis.

Authors:  Lucio De Maria; Lodovico Terzi di Bergamo; Alfredo Conti; Kazuhiko Hayashi; Valentina Pinzi; Taro Murai; Rachelle Lanciano; Sigita Burneikiene; Michela Buglione di Monale; Stefano Maria Magrini; Marco Maria Fontanella
Journal:  Front Oncol       Date:  2021-03-29       Impact factor: 6.244

4.  A functional MRI study of presurgical cognitive deficits in glioma patients.

Authors:  Irena T Schouwenaars; Miek J de Dreu; Geert-Jan M Rutten; Nick F Ramsey; Johan M Jansma
Journal:  Neurooncol Pract       Date:  2020-09-12

5.  Gas Plasma Exposure of Glioblastoma Is Cytotoxic and Immunomodulatory in Patient-Derived GBM Tissue.

Authors:  Sander Bekeschus; Mikael Ispirjan; Eric Freund; Frederik Kinnen; Juliane Moritz; Fariba Saadati; Jacqueline Eckroth; Debora Singer; Matthias B Stope; Kristian Wende; Christoph A Ritter; Henry W S Schroeder; Sascha Marx
Journal:  Cancers (Basel)       Date:  2022-02-05       Impact factor: 6.639

Review 6.  Advanced Imaging Techniques for Newly Diagnosed and Recurrent Gliomas.

Authors:  Luis R Carrete; Jacob S Young; Soonmee Cha
Journal:  Front Neurosci       Date:  2022-02-23       Impact factor: 4.677

7.  Diagnostic Yield and Complication Rate of Stereotactic Biopsies in Precision Medicine of Gliomas.

Authors:  Sophie Katzendobler; Anna Do; Jonathan Weller; Mario M Dorostkar; Nathalie L Albert; Robert Forbrig; Maximilian Niyazi; Rupert Egensperger; Niklas Thon; Joerg Christian Tonn; Stefanie Quach
Journal:  Front Neurol       Date:  2022-03-30       Impact factor: 4.003

8.  Chaperonology: The Third Eye on Brain Gliomas.

Authors:  Francesca Graziano; C Caruso Bavisotto; A Marino Gammazza; Francesca Rappa; Everly Conway de Macario; Albert J L Macario; Francesco Cappello; Claudia Campanella; Rosario Maugeri; Domenico Gerardo Iacopino
Journal:  Brain Sci       Date:  2018-06-14

9.  Non-enhancing gliomas: does intraoperative ultrasonography improve resections?

Authors:  Aliasgar V Moiyadi; Prakash Shetty; Robin John
Journal:  Ultrasonography       Date:  2018-07-29

Review 10.  Functional Mapping before and after Low-Grade Glioma Surgery: A New Way to Decipher Various Spatiotemporal Patterns of Individual Neuroplastic Potential in Brain Tumor Patients.

Authors:  Hugues Duffau
Journal:  Cancers (Basel)       Date:  2020-09-13       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.